FAQ/Help |
Calendar |
Search |
Today's Posts |
06-18-2020, 03:52 PM | #1 | |||
|
||||
Senior Member
|
This article from Medscape Today (June 5, 2020) indicates that the new oral disease-modifying treatments for MS haven't been as popular as they were expected to be--and Ocrevus seems to be the favorite DMT--"Newest oral DMTs haven't yet made a big impact in the MS world":
Newest Oral DMTs Haven't Yet Made a Big Impact in the MS World
__________________
Repeal the law of gravity! MS diagnosed 1980. Type 2 diabetes, osteoarthritis, osteopenia. Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, 12/16/20 - 3/16/24 |
|||
Reply With Quote |
06-20-2020, 06:01 PM | #2 | |||
|
||||
Elder
|
I tried two of them and the side effects were too harsh for me.
__________________
Wiz Turn Left at the next election. . RRMS DX 01/28/03 Started Copaxone again on 12/09/09 |
|||
Reply With Quote |
06-20-2020, 07:22 PM | #3 | |||
|
||||
Senior Member
|
Just because it seems easier, you'd think people would prefer an oral treatment but when I think about making that choice, I'd stick with an injection or even an infusion over a pill--but I'm not sure why.
__________________
Repeal the law of gravity! MS diagnosed 1980. Type 2 diabetes, osteoarthritis, osteopenia. Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, 12/16/20 - 3/16/24 |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||